Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | - |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 2.28 | 2.27 |
NAV | ₹12.59 | ₹157.96 |
Fund Started | 16 Aug 2023 | 13 Oct 2005 |
Fund Size | ₹854.34 Cr | ₹1330.73 Cr |
Exit Load | Exit load of 1%, if redeemed within 1 year. | Exit load of 1% if redeemed within 15 days. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 6.97% | 12.66% |
3 Year | - | 20.51% |
5 Year | - | 26.91% |
1 Year
3 Year
5 Year
Equity | 95.97% | 95.64% |
Cash | 3.96% | 3.99% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
Info Edge (India) Ltd. | 4.92% |
Eternal Ltd. | 4.21% |
Suzlon Energy Ltd. | 3.54% |
Affle (India) Ltd. | 3.49% |
Ami Organics Ltd. | 3.47% |
Awfis Space Solutions Ltd. | 3.32% |
The Federal Bank Ltd. | 3.26% |
GE Vernova T&D India Ltd. | 3.05% |
PB Fintech Ltd. | 3.04% |
Krishna Institute of Medical Sciences Ltd | 2.87% |
Name | Assets |
---|---|
ICICI Bank Ltd. | 8.08% |
HDFC Bank Ltd. | 6.24% |
Reliance Industries Ltd. | 6.14% |
Axis Bank Ltd. | 5.79% |
State Bank of India | 5.53% |
NTPC Ltd. | 5.47% |
Infosys Ltd. | 4.92% |
Larsen & Toubro Ltd. | 4.09% |
Bharti Airtel Ltd. | 4.05% |
Sun Pharmaceutical Industries Ltd. | 3.24% |
Name | Hardick Bora | Sri Sharma |
Start Date | 25 Jan 2023 | 30 Apr 2021 |
Name
Start Date
Description | The Scheme seeks to achieve long term capital appreciation by investing predominantly in equity and equity related securities of Innovative Companies. | The scheme seeks to generate capital appreciation and income distribution to unit holders by investing predominantly in equity/equity related securities of the companies belonging to Exports & Services industry. |
Launch Date | 16 Aug 2023 | 13 Oct 2005 |
Description
Launch Date